HNRNPA2B1 and colorectal carcinoma: Subsequently, cell immunofluorescence assays revealed that the process by which MIR181A1HG was transferred from highly metastatic CRC cells to HSCs via EVs could be inhibited by the knockdown of HNRNPA2B1 expression in RKO and SW620 cells (Fig. 3i, j).